About Us
腎臓内科について
業績
2014年
原著
Haruyama N, Fujisaki K, Yamato M, Eriguchi M, Noguchi H, Torisu K, Tsuruya K, Kitazono T: Improvement in spatial memory dysfunction by telmisartan through reduction of brain angiotensin II and oxidative stress in experimental uremic mice.
Life Sci, 113: 55-59, 2014Yoshitomi R, Nakayama M, Ura Y, Kuma K, Nishimoto H, Fukui A, Ikeda H, Tsuchihashi T, Tsuruya K, Kitazono T: Ankle-brachial blood pressure index predicts cardiovascular events and mortality in Japanese patients with chronic kidney disease not on dialysis.
Hypertens Res, 37: 1050-1055, 2014Fujisaki K, Tsuruya K, Nakano T, Taniguchi M, Higashi H, Katafuchi R, Kanai H, Nakayama M, Hirakata H, Kitazono T, Impact of Combined Losartan/Hydrochlorothiazide on Proteinuria in Patients with Chronic Kidney D, Hypertension Study I: Impact of combined losartan/hydrochlorothiazide on proteinuria in patients with chronic kidney disease and hypertension.
Hypertens Res, 37: 993-998, 2014Yamada S, Tokumoto M, Tatsumoto N, Taniguchi M, Noguchi H, Nakano T, Masutani K, Ooboshi H, Tsuruya K, Kitazono T: Phosphate overload directly induces systemic inflammation and malnutrition as well as vascular calcification in uremia.
Am J Physiol Renal Physiol, 306: F1418-1428, 2014Yamada S, Tsuruya K, Taniguchi M, Yoshida H, Tokumoto M, Hasegawa S, Tanaka S, Eriguchi M, Nakano T, Kitazono T: Relationship between residual renal function and serum fibroblast growth factor 23 in patients on peritoneal dialysis.
Ther Apher Dial, 18: 383-390, 2014Tsuruya K, Yoshida H, Nagata M, Kitazono T, Hirakata H, Iseki K, Moriyama T, Yamagata K, Yoshida H, Fujimoto S, Asahi K, Kurahashi I, Ohashi Y, Watanabe T: Association of the triglycerides to high-density lipoprotein cholesterol ratio with the risk of chronic kidney disease: analysis in a large Japanese population.
Atherosclerosis, 233: 260-267, 2014Izumaru K, Ninomiya T, Nagata M, Usui T, Yoshida D, Yonemoto K, Fukuhara M, Tsuruya K, Kitazono T, Kiyohara Y: Serum 1,25-dihydroxyvitamin d and the development of kidney dysfunction in a Japanese community.
Circ J, 78: 732-737, 2014Haruyama N, Tsuchimoto A, Masutani K, Nagata M, Kitada H, Tanaka M, Tsuruya K, Kitazono T: Subclinical nephrosclerosis is linked to left ventricular hypertrophy independent of classical atherogenic factors.
Hypertens Res, 37: 472-477, 2014Yoshitomi R, Fukui A, Nakayama M, Ura Y, Ikeda H, Oniki H, Tsuchihashi T, Tsuruya K, Kitazono T: Sex differences in the association between serum uric acid levels and cardiac hypertrophy in patients with chronic kidney disease.
Hypertens Res, 37: 246-252, 2014Matsui M, Takeda Y, Uemura S, Matsumoto T, Seno A, Onoue K, Tsushima H, Morimoto K, Soeda T, Okayama S, Somekawa S, Samejima K, Kawata H, Kawakami R, Nakatani K, Iwano M, Saito Y: Suppressed soluble Fms-like tyrosine kinase-1 production aggravates atherosclerosis in chronic kidney disease.
Kidney Int, 85: 393-403, 2014Fujisaki K, Tsuruya K, Yamato M, Toyonaga J, Noguchi H, Nakano T, Taniguchi M, Tokumoto M, Hirakata H, Kitazono T: Cerebral oxidative stress induces spatial working memory dysfunction in uremic mice: neuroprotective effect of tempol.
Nephrol Dial Transplant, 29: 529-538, 2014
共同研究
Iseki K, Tsuruya K, Kanda E, Nomura T, Hirakata H: Effects of sleepiness on survival in Japanese hemodialysis patients: J-DOPPS study. Nephron Clin Pract, 128: 333-340, 2014
- Wakasugi M, Kazama JJ, Narita I, Iseki K, Moriyama T, Yamagata K, Fujimoto S, Tsuruya K, Asahi K, Konta T, Kimura K, Kondo M, Kurahashi I, Ohashi Y, Watanabe T: Association between combined lifestyle factors and non-restorative sleep in Japan: a cross-sectional study based on a Japanese health database. PLoS One, 9: e108718, 2014
Yano Y, Fujimoto S, Sato Y, Konta T, Iseki K, Iseki C, Moriyama T, Yamagata K, Tsuruya K, Narita I, Kondo M, Kimura K, Asahi K, Kurahashi I, Ohashi Y, Watanabe T: New-onset hypertension and risk for chronic kidney disease in the Japanese general population.
J Hypertens, 32: 2371-2377; discussion 2377, 2014Kamei K, Konta T, Hirayama A, Suzuki K, Ichikawa K, Fujimoto S, Iseki K, Moriyama T, Yamagata K, Tsuruya K, Kimura K, Narita I, Kondo M, Asahi K, Watanabe T: A slight increase within the normal range of serum uric acid and the decline in renal function: associations in a community-based population.
Nephrol Dial Transplant, 29: 2286-2292, 2014Nagai K, Yamagata K, Ohkubo R, Saito C, Asahi K, Iseki K, Kimura K, Moriyama T, Narita I, Fujimoto S, Tsuruya K, Konta T, Kondo M, Watanabe T: Annual decline in estimated glomerular filtration rate is a risk factor for cardiovascular events independent of proteinuria.
Nephrology (Carlton), 19: 574-580, 2014Kondo M, Yamagata K, Hoshi SL, Saito C, Asahi K, Moriyama T, Tsuruya K, Konta T, Fujimoto S, Narita I, Kimura K, Iseki K, Watanabe T: Budget impact analysis of chronic kidney disease mass screening test in Japan.
Clin Exp Nephrol, 18: 885-891, 2014Ishigami T, Yamamoto R, Nagasawa Y, Isaka Y, Rakugi H, Iseki K, Yamagata K, Tsuruya K, Yoshida H, Fujimoto S, Asahi K, Kurahashi I, Ohashi Y, Moriyama T, Watanabe T: An association between serum gamma-glutamyltransferase and proteinuria in drinkers and non-drinkers: a Japanese nationwide cross-sectional survey.
Clin Exp Nephrol, 18: 899- 910, 2014Sato Y, Fujimoto S, Konta T, Iseki K, Moriyama T, Yamagata K, Tsuruya K, Yoshida H, Asahi K, Kurahashi I, Ohashi Y, Watanabe T: U-shaped association between body mass index and proteinuria in a large Japanese general population sample.
Clin Exp Nephrol, 18: 75-86, 2014
症例報告
Yamada S, Uemura M, Tokumoto M, Nagara T, Noguchi H, Hirahashi M, Nakano T, Tsuruya K, Kitazono T: Hypercalcemia induced by Rosai-Dorfman disease in a hemodialysis patient: histological evidence of extrarenal calcitriol overproduction.
Intern Med, 53: 2783-2787, 2014Yamada S, Tsuchimoto A, Kaizu Y, Taniguchi M, Masutani K, Tsukamoto H, Ooboshi H, Tsuruya K, Kitazono T: Tocilizumab-induced remission of nephrotic syndrome accompanied by secondary amyloidosis and glomerulonephritis in a patient with rheumatoid arthritis.
CEN Case Rep, 3: 237-243, 2014Matsukuma Y, Sugawara K, Shimano S, Yamada S, Tsuruya K, Kitazono T, Higashi H: A case of bacterial peritonitis caused by Roseomonas mucosa in a patient undergoing continuous ambulatory peritoneal dialysis.
CEN Case Rep, 3: 127-131, 2014Matsui M, Okayama S, Tsushima H, Samejima K, Kanki T, Hasegawa A, Morimoto K, Akai Y, Takano M, Uemura S, Ohbayashi C, Saito Y: Therapeutic Benefits of Tocilizumab Vary in Different Organs of a Patient with AA Amyloidosis.
Case Rep Nephrol, 2014: 823093, 2014Sueta S, Kondo M, Matsubara T, Yasuhara Y, Akiyama S, Imai E, Amaike H, Tagawa M: Membranous nephropathy associated with type 1 autoimmune pancreatitis and dominant glomerular IgG4 deposit.
CEN Case Rep, 3: 18-23, 2014Yamada, S, Uemura, M, Tokumoto, M, Nagara, T, Noguchi, H, Hirahashi, M, Nakano, T, Tsuruya, K, Kitazono, T: Hypercalcemia induced by Rosai-Dorfman disease in a hemodialysis patient: histological evidence of extrarenal calcitriol overproduction.
Intern Med, 53: 2783-2787, 2014.Yamada, S, Tsuchimoto, A, Kaizu, Y, Taniguchi, M, Masutani, K, Tsukamoto, H, Ooboshi, H, Tsuruya, K, Kitazono, T: Tocilizumab-induced remission of nephrotic syndrome accompanied by secondary amyloidosis and glomerulonephritis in a patient with rheumatoid arthritis.
CEN Case Rep, 3: 237-243, 2014.Matsukuma, Y, Sugawara, K, Shimano, S, Yamada, S, Tsuruya, K, Kitazono, T, Higashi, H: A case of bacterial peritonitis caused by Roseomonas mucosa in a patient undergoing continuous ambulatory peritoneal dialysis.
CEN Case Rep, 3: 127-131, 2014.Matsui, M, Okayama, S, Tsushima, H, Samejima, K, Kanki, T, Hasegawa, A, Morimoto, K, Akai, Y, Takano, M, Uemura, S, Ohbayashi, C, Saito, Y: Therapeutic Benefits of Tocilizumab Vary in Different Organs of a Patient with AA Amyloidosis.
Case Rep Nephrol, 2014: 823093, 2014.Sueta, S, Kondo, M, Matsubara, T, Yasuhara, Y, Akiyama, S, Imai, E, Amaike, H, Tagawa, M: Membranous nephropathy associated with type 1 autoimmune pancreatitis and dominant glomerular IgG4 deposit.
CEN Case Rep, 3: 18-23, 2014.
